Advertisement
Advertisement
EVAX
Evaxion A/S - ADR
3.00
USDSponsored
+0.24
+8.70%
Nov 06, 15:59 UTC -5
Closed
After-Market
2.93
-0.07
-2.20%
Evaxion A/S - ADR (EVAX) Earnings
EVAX Earnings Reports
Positive Surprise Ratio
EVAX beat 14 of 23 last estimates.
61%
Next Report
Date of Next Report
Nov 19, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.29
Implied change from Q2 26 (Revenue/ EPS)
--
/-42.00%
Implied change from Q3 25 (Revenue/ EPS)
-100.00%
/-158.00%
Evaxion A/S - ADR earnings per share and revenue
On Aug 20, 2026, EVAX reported earnings of -0.50 USD per share (EPS) for Q2 26, missing the estimate of -0.31 USD, resulting in a -56.45% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.13% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.29 USD, with revenue projected to reach -- USD, implying an decrease of -42.00% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nyxoah SA Ordinary Shares
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.30
Actual
-$0.17
Surprise
+42.29%
10x Genomics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.15
Surprise
+43.35%
Doximity, Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$0.35
Actual
$0.36
Surprise
+0.56%
iRhythm Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.06
Actual
$0.82
Surprise
+1,214.10%
Privia Health Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.10
Surprise
+3.73%
Schrodinger, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.70
Actual
-$0.50
Surprise
+29.57%
Enovis Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.78
Actual
$0.88
Surprise
+12.07%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Health Catalyst, Inc Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.03
Surprise
+38.14%
FAQ
What were Evaxion A/S - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Evaxion A/S - ADR reported EPS of -$0.50, missing estimates by -56.45%, and revenue of $0.00, 0% as expectations.
How did the market react to Evaxion A/S - ADR's Q2 2026 earnings?
The stock price moved up 4.13%, changed from $3.15 before the earnings release to $3.28 the day after.
When is Evaxion A/S - ADR expected to report next?
The next earning report is scheduled for Nov 19, 2026.
What are the forecasts for Evaxion A/S - ADR's next earnings report?
Based on 3
analysts, Evaxion A/S - ADR is expected to report EPS of -$0.29 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.